Eagle Health Investments LP

Registered adviser

CIK

1842545

Location

Greenwich, CT

Portfolio Value

Small $603,309,941

Diversification

Diversified

Filing Date

Global Rank

#3,319 / 8,807 ▼ 217

Top Industry

Biotechnology 64.2%

Period ended 4 months ago

Filed Aug 10, 2026 · 2mo

23 quarters · since Dec 2020

Regulatory profile

From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.

Holder type

Registered adviser

Form ADV roster, Oct 1, 2026

Form ADV adviser

CRD 309210

Roster of Oct 1, 2026

Regulatory AUM

$605,257,757

Main clients

Pooled investment vehicles (100% of AUM)

Private funds

1 fund · Hedge funds

Focus by fund count, roster of Oct 1, 2026

$605,257,757 gross assets

Private funds on Schedule D 7.B.(1)

As filed Mar 28, 2024; SEC's bulk Form ADV archive ends with 2024 filings.

$800,175,750 gross assets in 1 fund Hedge funds $800,175,750 (1)

Form ADV history

Monthly rosters from Dec 2019; each row is a run with the same figures, newest first.

Rosters	Regulatory AUM	Main clients
Apr 2026 to Oct 2026	$605,257,757	Pooled investment vehicles (100%)
Apr 2025 to Mar 2026	$711,903,596	Pooled investment vehicles (100%)
Apr 2024 to Mar 2025	$698,387,052	Pooled investment vehicles (100%)
May 2023 to Mar 2024	$637,089,261	Pooled investment vehicles (100%)
Apr 2023	$637,089,261	Pooled investment vehicles (100%)
Apr 2022 to Mar 2023	$525,423,762	Pooled investment vehicles (100%)

2 earlier changes not shown.

Portfolio style

Measured from the filed 13F common-share book for Jun 30, 2026, never from the firm's own description.

Style

Concentrated

The top 10 positions are 66.1% of the book (60%+)

Turnover

Medium turnover

50.6% over the last four quarters (30% to under 100%)

Horizon

Medium horizon

Value-weighted holding period 8.2 quarters (4 to under 12)

Closest benchmark: the Russell 2000 as of 2026-06-30, active share 98.9%; sector active share 90.6% against the combined 13F book's sector weights.

Over time 23 measured quarters

How the bands are measured

Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.

Clone Performance

Build a hypothetical price-return history from this filer's public 13F holdings.

View clone backtest

Portfolio Concentration

27 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026

Top Position

11.8%

−5.5 pts

Top 5

40.8%

−6.1 pts

Top 10

66.1%

−3.0 pts

HHI

581

Diversified−133

Portfolio Trend

23 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2026

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$603,309,941	27

Last Quarter's Activity

Export CSV

Jun 30, 2026 vs Mar 31, 2026

Added To

Positions the filer increased

10 positions

Ticker	Company	Δ Shares	Shares	Value
INSM	INSMED Inc	+159,859	384,130	$40,955,940
BMRN	Biomarin Pharmaceutical Inc	+118,867	624,676	$35,743,960
BSX	Boston Scientific Corp	+76,012	369,164	$15,755,919
PTGX	Protagonist Therapeutics, Inc	+69,000	248,322	$30,439,310
SRRK	Scholar Rock Holding Corp	+61,253	555,272	$30,539,960
ALKS	Alkermes plc.	+58,629	297,302	$15,578,624
KYMR	Kymera Therapeutics, Inc.	+20,332	166,148	$19,052,191
ASND	Ascendis Pharma A/S	+19,508	106,158	$28,314,461
RVMD	Revolution Medicines, Inc.	+882	120,346	$22,538,398
ARGX	Argenx SE	+81	76,417	$70,897,400
No positions match the current search.

Trimmed

Positions the filer reduced

4 positions

Ticker	Company	Δ Shares	Shares	Value
FTRE	Fortrea Holdings Inc.	−126,286	1,181,274	$20,554,167
NTRA	Natera, Inc.	−106,030	15,847	$4,301,668
ICLR	Icon PLC	−50,357	308,143	$53,527,520
GH	Guardant Health, Inc.	−9,596	300,685	$45,111,770
No positions match the current search.

New Positions

Positions the filer opened this quarter

5 positions

Ticker	Company	Shares	Value
AXSM	Axsome Therapeutics, Inc.	65,051	$15,922,533
IONS	Ionis Pharmaceuticals Inc	194,577	$15,428,010
DNTH	Dianthus Therapeutics, Inc. /DE/	131,344	$12,803,413
AVTX	Avalo Therapeutics, Inc.	235,093	$4,344,518
LLY	ELI LILLY & Co	1,994	$2,391,663
No positions match the current search.

Sold Out

Positions the filer fully exited

4 positions

Ticker	Company	Shares	Value
BBIO	BridgeBio Pharma, Inc.	267,031	$19,829,722
PRCT	PROCEPT BioRobotics Corp	483,815	$12,100,213
CNTA	Centessa Pharmaceuticals plc	214,291	$0
—		412,497	$0
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

27 tracked positions · $603,309,941 total · filing declares 27 positions · $603,308,468 · as of Jun 30, 2026

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	Held (qtrs)	Est. cost/share	% of Portfolio
ARGX	Argenx SE Healthcare	Added	76,417	+81	$70,897,400	+27.2%	23	before history	11.75%
ICLR	Icon PLC Healthcare	Reduced	308,143	-50,357	$53,527,520	+34.9%	15	$184.29	8.87%
GH	Guardant Health, Inc. Healthcare	Reduced	300,685	-9,596	$45,111,770	+57.4%	5	$51.63	7.48%
INSM	INSMED Inc Healthcare	Added	384,130	+159,859	$40,955,940	+11.7%	9	$77.04	6.79%
BMRN	Biomarin Pharmaceutical Inc Healthcare	Added	624,676	+118,867	$35,743,960	+25.1%	9	$72.37	5.92%
ILMN	Illumina, Inc. Healthcare	Held	187,413	0	$32,952,827	+42.6%	17	unpriced	5.46%
SRRK	Scholar Rock Holding Corp Healthcare	Added	555,272	+61,253	$30,539,960	+25.8%	5	$37.02	5.06%
PTGX	Protagonist Therapeutics, Inc Healthcare	Added	248,322	+69,000	$30,439,310	+61.0%	3	$91.42	5.05%
RARE	Ultragenyx Pharmaceutical Inc. Healthcare	Held	884,121	0	$29,520,800	+59.4%	2	$22.52	4.89%
CMPS	COMPASS Pathways plc Healthcare	Held	2,060,427	0	$29,155,042	+155.9%	4	$5.53	4.83%
ASND	Ascendis Pharma A/S Healthcare	Added	106,158	+19,508	$28,314,461	+42.9%	2	$225.90	4.69%
RVMD	Revolution Medicines, Inc. Healthcare	Added	120,346	+882	$22,538,398	+94.0%	3	$67.21	3.74%
FTRE	Fortrea Holdings Inc. Healthcare	Reduced	1,181,274	-126,286	$20,554,167	+66.9%	4	$8.83	3.41%
KYMR	Kymera Therapeutics, Inc. Healthcare	Added	166,148	+20,332	$19,052,191	+56.9%	3	$70.45	3.16%
AXSM	Axsome Therapeutics, Inc. Healthcare	NEW	65,051	NEW	$15,922,533	NEW	1	$216.87	2.64%
BSX	Boston Scientific Corp Healthcare	Added	369,164	+76,012	$15,755,919	−14.3%	2	$74.71	2.61%
ALKS	Alkermes plc. Healthcare	Added	297,302	+58,629	$15,578,624	+84.6%	4	$31.83	2.58%
IONS	Ionis Pharmaceuticals Inc Healthcare	NEW	194,577	NEW	$15,428,010	NEW	1	$75.25	2.56%
TEM	Tempus AI, Inc. Healthcare	Held	256,269	0	$14,845,663	+28.1%	2	$56.83	2.46%
DNTH	Dianthus Therapeutics, Inc. /DE/ Healthcare	NEW	131,344	NEW	$12,803,413	NEW	1	$87.34	2.12%
		Held	1,709,359	0	$9,008,321	+48.9%	2	$3.76	1.49%
AVTX	Avalo Therapeutics, Inc. Healthcare	NEW	235,093	NEW	$4,344,518	NEW	1	$15.81	0.72%
NTRA	Natera, Inc. Healthcare	Reduced	15,847	-106,030	$4,301,668	−82.4%	23	before history	0.71%
LLY	ELI LILLY & Co Healthcare	NEW	1,994	NEW	$2,391,663	NEW	1	$1,021.74	0.40%
ISRG	Intuitive Surgical Inc Healthcare	Held	4,390	0	$1,745,815	−13.7%	17	$230.55	0.29%
IMCR	Immunocore Holdings plc Healthcare	Held	46,300	0	$1,470,025	+5.3%	11	$51.98	0.24%
FRNM	Freenome, Inc. Healthcare	Held	37,686	0	$410,023	−0.8%	2	$12.76	0.07%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.